BioSpace News Archive

Drug Development

Surface Ophthalmics Announces First Patient Dosed in Landmark Head-to-Head Phase II Trial for SURF-100 for Chronic Dry Eye Disease

Surface Ophthalmics, Inc., a pharmaceutical company focused on the development and commercialization of innovative therapeutics for ocular diseases, today announced that the first patient has been dosed in the Phase II clinical trial for its investigational product SURF-100 (mycophenolate sodium and betamethasone sodium phosphate in Klarity® vehicle) for the treatment of chronic dry eye disease.

January 27, 2021
·
4 min read
Pharm Country

National Kidney Foundation Honors UnitedHealth Group with 2021 Corporate Innovator Award

Company recognized for developing the first-of-its-kind program designed to support employees, and boost the critically low number of living donor organ transplants

January 27, 2021
·
4 min read
Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System again shown to significantly reduce surgical site complications

Smith+Nephew, the global medical technology business, is pleased to announce a new publication showing that its PICO Single Use Negative Pressure Wound Therapy System significantly reduced the odds of surgical site infections by 63%*, the odds of seroma by 77%†, and the odds of dehiscence by 30%‡.

January 27, 2021
·
8 min read
Singapore-based Osteopore International Collaborates With Maastricht University Medical Centre To Develop Implant Solution That Prevents Leg Amputations

Osteopore and Maastricht University Medical Centre has developed a first-of-its-kind, bioresorbable bone implant solution that prevents leg amputations in patients with severe lower leg fractures

January 27, 2021
·
3 min read